Fresenius Medical Care AG KGaA Debt to Equity Ratio 2012-2025 | FMS
Current and historical debt to equity ratio values for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Fresenius Medical Care AG KGaA debt/equity for the three months ending December 31, 2025 was 0.45.
| Fresenius Medical Care AG KGaA Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-12-31 | $18.92B | $16.16B | 1.17 |
| 2025-09-30 | $19.85B | $16.26B | 1.22 |
| 2025-06-30 | $19.26B | $16.26B | 1.18 |
| 2025-03-31 | $18.15B | $16.33B | 1.11 |
| 2024-12-31 | $19.26B | $17.06B | 1.13 |
| 2024-09-30 | $19.49B | $16.26B | 1.20 |
| 2024-06-30 | $20.15B | $16.36B | 1.23 |
| 2024-03-31 | $20.85B | $16.43B | 1.27 |
| 2023-12-31 | $20.68B | $16.05B | 1.29 |
| 2023-09-30 | $21.99B | $16.80B | 1.31 |
| 2023-06-30 | $21.84B | $16.28B | 1.34 |
| 2023-03-31 | $21.76B | $16.35B | 1.33 |
| 2022-12-31 | $21.39B | $16.28B | 1.31 |
| 2022-09-30 | $21.83B | $16.86B | 1.30 |
| 2022-06-30 | $21.94B | $16.44B | 1.33 |
| 2022-03-31 | $22.65B | $16.32B | 1.39 |
| 2021-12-31 | $24.12B | $16.54B | 1.46 |
| 2021-09-30 | $24.04B | $15.86B | 1.52 |
| 2021-06-30 | $24.31B | $15.44B | 1.58 |
| 2021-03-31 | $24.06B | $15.91B | 1.51 |
| 2020-12-31 | $22.11B | $14.09B | 1.57 |
| 2020-09-30 | $23.84B | $14.80B | 1.61 |
| 2020-06-30 | $22.98B | $14.67B | 1.57 |
| 2020-03-31 | $22.95B | $14.64B | 1.57 |
| 2019-12-31 | $22.07B | $14.82B | 1.49 |
| 2019-09-30 | $21.82B | $15.06B | 1.45 |
| 2019-06-30 | $21.53B | $14.39B | 1.50 |
| 2019-03-31 | $21.72B | $15.02B | 1.45 |
| 2018-12-31 | $15.76B | $15.24B | 1.03 |
| 2018-09-30 | $15.40B | $14.36B | 1.07 |
| 2018-06-30 | $15.58B | $14.29B | 1.09 |
| 2018-03-31 | $16.28B | $13.41B | 1.21 |
| 2017-12-31 | $14.92B | $12.24B | 1.22 |
| 2017-09-30 | $15.96B | $12.54B | 1.27 |
| 2017-06-30 | $15.43B | $11.76B | 1.31 |
| 2017-03-31 | $15.43B | $12.04B | 1.28 |
| 2016-12-31 | $15.48B | $11.46B | 1.35 |
| 2016-09-30 | $15.42B | $11.24B | 1.37 |
| 2016-06-30 | $15.72B | $10.83B | 1.45 |
| 2016-03-31 | $15.26B | $10.81B | 1.41 |
| 2015-12-31 | $14.87B | $10.50B | 1.42 |
| 2015-09-30 | $15.17B | $10.24B | 1.48 |
| 2015-06-30 | $14.98B | $10.43B | 1.44 |
| 2015-03-31 | $14.73B | $10.38B | 1.42 |
| 2014-12-31 | $15.35B | $10.03B | 1.53 |
| 2014-09-30 | $13.73B | $10.52B | 1.31 |
| 2014-06-30 | $13.82B | $10.32B | 1.34 |
| 2014-03-31 | $13.11B | $10.31B | 1.27 |
| 2013-12-31 | $12.99B | $10.13B | 1.28 |
| 2013-09-30 | $12.80B | $9.74B | 1.31 |
| 2013-06-30 | $12.68B | $9.65B | 1.31 |
| 2013-03-31 | $12.24B | $9.90B | 1.24 |
| 2012-12-31 | $12.60B | $9.73B | 1.29 |
| 2012-09-30 | $12.42B | $9.44B | 1.32 |
| 2012-06-30 | $12.73B | $9.01B | 1.41 |
| 2012-03-31 | $12.85B | $9.14B | 1.41 |
| 2011-12-31 | $11.06B | $8.47B | 1.31 |
| 2011-09-30 | $10.41B | $8.22B | 1.27 |
| 2011-06-30 | $10.83B | $8.23B | 1.32 |
| 2011-03-31 | $10.24B | $7.88B | 1.30 |
| 2010-12-31 | $9.29B | $7.80B | 1.19 |
| 2010-09-30 | $9.23B | $7.47B | 1.24 |
| 2010-06-30 | $9.07B | $6.93B | 1.31 |
| 2010-03-31 | $8.75B | $7.13B | 1.23 |
| 2009-12-31 | $8.79B | $7.03B | 1.25 |
| 2009-09-30 | $8.98B | $6.71B | 1.34 |
| 2009-06-30 | $8.95B | $6.39B | 1.40 |
| 2009-03-31 | $8.63B | $6.24B | 1.38 |
| 2008-12-31 | $8.96B | $5.96B | 1.50 |
| 2008-09-30 | $8.88B | $5.91B | 1.50 |
| 2008-06-30 | $9.09B | $5.83B | 1.56 |
| 2008-03-31 | $8.78B | $5.81B | 1.51 |
| 2007-12-31 | $8.60B | $5.58B | 1.54 |
| 2007-09-30 | $8.43B | $5.33B | 1.58 |
| 2007-06-30 | $8.45B | $5.10B | 1.66 |
| 2007-03-31 | $8.20B | $5.05B | 1.62 |
| 2006-12-31 | $8.18B | $4.87B | 1.68 |
| 2006-09-30 | $8.03B | $4.63B | 1.73 |
| 2006-06-30 | $8.15B | $4.49B | 1.82 |
| 2006-03-31 | $8.68B | $4.47B | 1.94 |
| 2005-12-31 | $4.01B | $3.97B | 1.01 |
| 2005-09-30 | $2.93B | $5.04B | 0.58 |
| 2005-06-30 | $2.95B | $4.86B | 0.61 |
| 2005-03-31 | $2.93B | $4.96B | 0.59 |
| 2004-12-31 | $3.05B | $4.91B | 0.62 |
| 2004-09-30 | $3.06B | $4.67B | 0.66 |
| 2004-06-30 | $3.17B | $4.50B | 0.70 |
| 2004-03-31 | $3.18B | $4.53B | 0.70 |
| 2003-12-31 | $3.02B | $4.49B | 0.67 |
| 2003-09-30 | $3.41B | $1.89B | 1.80 |
| 2003-06-30 | $2.60B | $2.64B | 0.98 |
| 2003-03-31 | $3.42B | $1.76B | 1.94 |
| 2002-12-31 | $2.52B | $2.49B | 1.01 |
| 2002-09-30 | $2.56B | $2.44B | 1.05 |
| 2002-06-30 | $3.36B | $1.67B | 2.01 |
| 2002-03-31 | $2.66B | $2.33B | 1.14 |
| 2001-12-31 | $2.71B | $2.29B | 1.19 |
| 2001-09-30 | $2.49B | $2.46B | 1.02 |
| 2001-06-30 | $2.43B | $2.14B | 1.14 |
| 2001-03-31 | $2.88B | $1.72B | 1.68 |
| 2000-12-31 | $2.52B | $2.03B | 1.24 |
| 2000-09-30 | $2.94B | $1.70B | 1.73 |
| 2000-06-30 | $2.97B | $1.67B | 1.78 |
| 2000-03-31 | $2.97B | $1.65B | 1.81 |
| 1999-12-31 | $3.02B | $1.62B | 1.86 |
| 1999-09-30 | $3.20B | $1.60B | 2.00 |
| 1999-06-30 | $2.62B | $1.99B | 1.32 |
| 1999-03-31 | $2.64B | $1.97B | 1.34 |
| 1998-12-31 | $2.66B | $1.95B | 1.37 |
| 1998-09-30 | $2.68B | $1.95B | 1.37 |
| 1998-06-30 | $2.75B | $1.98B | 1.39 |
| 1998-03-31 | $2.84B | $2.04B | 1.39 |
| 1997-12-31 | $3.04B | $1.97B | 1.55 |
| 1997-09-30 | $3.72B | $0.48B | 7.75 |
| 1997-06-30 | $3.02B | $1.81B | 1.67 |
| 1997-03-31 | $2.89B | $1.77B | 1.63 |
| 1996-12-31 | $4.31B | $0.63B | 6.82 |
| 1996-09-30 | $2.86B | $1.20B | 2.39 |
| 1996-06-30 | $5.04B | $1.27B | 3.98 |
| 1996-03-31 | $5.16B | $1.33B | 3.87 |
| 1995-12-31 | $5.07B | $1.23B | 4.11 |
| 1995-09-30 | $4.55B | $1.69B | 2.69 |
| 1995-06-30 | $4.41B | $1.67B | 2.64 |
| 1995-03-31 | $4.81B | $1.55B | 3.11 |
| 1994-12-31 | $4.73B | $1.51B | 3.14 |
| 1994-09-30 | $4.66B | $1.44B | 3.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $14.168B | $20.627B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $189.665B | 22.07 |
| Intuitive Surgical (ISRG) | United States | $172.536B | 66.55 |
| IDEXX Laboratories (IDXX) | United States | $50.254B | 48.15 |
| Edwards Lifesciences (EW) | United States | $44.027B | 29.64 |
| Alcon (ALC) | Switzerland | $39.174B | 26.40 |
| IQVIA Holdings (IQV) | United States | $28.430B | 15.36 |
| Mettler-Toledo (MTD) | United States | $27.662B | 31.81 |
| DexCom (DXCM) | United States | $26.948B | 33.50 |
| STERIS (STE) | Ireland | $24.357B | 24.64 |
| Waters (WAT) | United States | $19.256B | 24.63 |
| Coloplast (CLPBY) | Denmark | $17.511B | 26.79 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.334B | 0.00 |
| Penumbra (PEN) | United States | $13.288B | 93.47 |
| Globus Medical (GMED) | United States | $11.790B | 24.74 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $6.991B | 22.40 |
| Glaukos (GKOS) | United States | $6.287B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.363B | 17.75 |
| Teleflex (TFX) | United States | $4.585B | 7.31 |
| TransMedics (TMDX) | United States | $4.437B | 52.57 |
| LivaNova (LIVN) | United Kingdom | $3.593B | 19.41 |
| Integer Holdings (ITGR) | United States | $3.011B | 14.13 |
| Veracyte (VCYT) | United States | $2.828B | 32.22 |
| Elekta AB (EKTAY) | Sweden | $2.266B | 21.19 |
| Alphatec Holdings (ATEC) | United States | $1.985B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 21.79 |
| UFP Technologies (UFPT) | United States | $1.896B | 25.03 |
| Artivion (AORT) | United States | $1.734B | 58.10 |
| Pulse Biosciences (PLSE) | United States | $1.559B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.553B | 0.00 |
| AxoGen (AXGN) | United States | $1.533B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.03 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.882B | 4.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.692B | 13.80 |
| SiBone (SIBN) | United States | $0.665B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.614B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.612B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.35 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.530B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.516B | 0.00 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.500B | 13.03 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.329B | 54.76 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.283B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.235B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.183B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.175B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.156B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.146B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.132B | 0.00 |
| CVRx (CVRX) | United States | $0.130B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.091B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Positron (POSC) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Accuray (ARAY) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |